Peiyi Xie
8PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 18, 2025
TREM2 facilitates gastric cancer progression and immune evasion via inhibiting TRIM21-mediated STAT1 degradation in tumor-associated macrophages.Zihao Zhang, Kuan Yu, Yifan Cao
|Oct 07, 2025
Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma.Wenxin Xu, Yufei Zhao, Jialei Weng
|Aug 22, 2025
Liver regeneration-associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition.Qiang Yu, Mincheng Yu, Peiyi Xie
|Jun 16, 2025
SIRPĪ± blockade therapy potentiates immunotherapy by inhibiting PD-L1+ myeloid cells in hepatocellular carcinoma.Da Huang, Min Xu, Hui Wang
|May 02, 2025
FMO2+ cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma.Wenxin Xu, Jialei Weng, Yufei Zhao
|Nov 04, 2024
ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis.Peiyi Xie, Lei Guo, Qiang Yu
Pageof 2
